Ken is the founder and principal of Skyemar Consulting specializing in the development of strategic priorities and translation into near term goals in conjunction with senior management. Prior to Skyemar, Ken was the Director of Corporate Planning & Portfolio Management at Illumina where he led the development of the annual strategic, operating, and portfolio plans, as well as resource management across 200 projects and 1,500 resources. Previously he was Associate Director at Ionis Pharmaceuticals where he performed genomic analysis of targets for drug development and is an author on more than 400 patents. Ken conducted a postdoctoral fellowship at the Salk Institute, La Jolla and has published five papers in peer reviewed journals. Ken earned his B.Sc. with Honors in Genetics from the University of Glasgow, a Ph.D. in molecular biology from the University of Edinburgh, and an MBA in strategy and healthcare from the University of California San Diego.